Glen Clova Scientific

Developing a new generation of Active Biologic Drugs

Our Vision

Business Strategy

Growth through:

Transforming the clinical potential of biologic drugs

The Problem

Biological drugs, e.g. antibodies, are hugely successful but market penetration for many indications is incomplete due to inherent limitations including:

The Solution

A new class of Active Biologics featuring:

What’s unique about GCS technology?

Scroll to Top